BMS-470539
BMS-470539 is a small-molecule experimental drug which acts as a potent and highly selective full agonist of the MC 1 receptor.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BMS-470539 is a small-molecule experimental drug which acts as a potent and highly selective full agonist of the MC 1 receptor. It was discovered in 2003 as part of an effort to understand the role of the MC 1 receptor in immunomodulation, and has since been used in scientific research to determine its role in inflammatory processes.
The compound was designed with the intention of mimicking the central His-Phe-Arg-Trp pharmacophore of the melanocortins, and this proved to be successful based on its favorable pharmacodynamic profile.
See also
Afamelanotide Bremelanotide Melanotan II Modimelanotide Setmelanotide
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329169891 under CC BY-SA 4.0; modifications have been made.